ANALYST RECOMMENDATIONS : Nvidia, Nike, Linde, Republic Services, Idexx Laboratories...
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
- Avalara: Mizuho Securities downgrades to neutral from buy. PT is $93.5.
- Ball: Morgan Stanley maintains equal-weight rating. PT down to $56 from $75.
- Brunswick: BMO Capital Markets raised the recommendation to outperform from market perform. PT up 38% to $110.
- Charles River Laboratories: Deutsche bank cut the target to $270 from $290. Maintains buy rating.
- CRISPR Therapeutics: Chardan Research adjusts price target to $154 from $164. Reiterates buy rating.
- Idexx Laboratories: Piper Sandler maintains overweight rating. PT up to $500 from $420.
- Karuna Therapeutics: JPM Securities adjusts price target to $315 from $190. Maintains market outperform rating.
- Liberty Broadband: Rosenblatt Securitie downgrades to $163 from $184.
- Linde: Baader Helvea downgrades to reduce from add. PT up 5% to $316.45.
- Match Group: DA Davidson adjusts price target to $90 from $100. Reiterates buy rating.
- Nike: Exane BNP Paribas cut the recommendation to neutral from outperform. PT up 3.5% to $118.
- NVIDIA: Craig-Hallum downgrades to hold from buy. Lowers price target to $180 from $210.
- Republic Services: Raymon James maintains outperform rating. PT up to $155 from $143.
- TreeHouse Foods: Stifel raised the target to $45 from $38. Maintains hold rating.
- Trimble: Piper Sandler cut the target to $82 from $100. Maintains overweight rating.
- Tyson Foods: Piper Sandler upgrades to neutral from underweight. PT set to $79.
- Western Digital: Stifel maintains buy rating. PT down to $70 from $77.
By 
